207 related articles for article (PubMed ID: 35083488)
1. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
Shi T; Gao G
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
[TBL] [Abstract][Full Text] [Related]
2. Identification of prognostic genes in the pancreatic adenocarcinoma immune microenvironment by integrated bioinformatics analysis.
Wang H; Lu L; Liang X; Chen Y
Cancer Immunol Immunother; 2022 Jul; 71(7):1757-1769. PubMed ID: 34854950
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel potential homologous repair deficiency-associated genes in pancreatic adenocarcinoma via WGCNA coexpression network analysis and machine learning.
Liu C; Fang J; Kang W; Yang Y; Yu C; Chen H; Zhang Y; Ouyang H
Cell Cycle; 2023 Nov; 22(21-22):2392-2408. PubMed ID: 38124367
[TBL] [Abstract][Full Text] [Related]
4. EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in Pancreatic Adenocarcinoma.
Cao Z; Jing Y; Cheng C; Wang F; Guan M; Zhang K; Jiao J; Ruan L; Chen Z
Front Biosci (Landmark Ed); 2024 Mar; 29(3):119. PubMed ID: 38538250
[TBL] [Abstract][Full Text] [Related]
5. GNG7 and ADCY1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma through bioinformatic-based analyses.
Zhang Y; Yang J; Wang X; Li X
Sci Rep; 2021 Oct; 11(1):20441. PubMed ID: 34650124
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a novel cuproptosis signature for stratifying different prognostic, immune, metabolic, and therapeutic landscapes in pancreatic adenocarcinoma.
Yan X; Zheng W; Xu FS; Chang HL; Zhang Y; Zhang ZY; Zhang YH
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):2024-2050. PubMed ID: 38497885
[TBL] [Abstract][Full Text] [Related]
7. Potential Prognostic Value and Mechanism of Stromal-Immune Signature in Tumor Microenvironment for Stomach Adenocarcinoma.
Zhu X; Xie X; Zhao Q; Zhang L; Li C; Zhao D
Biomed Res Int; 2020; 2020():4673153. PubMed ID: 32685487
[TBL] [Abstract][Full Text] [Related]
8. Multi-omics pan-cancer study of SPTBN2 and its value as a potential therapeutic target in pancreatic cancer.
Chang H; Chen H; Ma T; Ma K; Li Y; Suo L; Liang X; Jia K; Ma J; Li J; Sun D
Sci Rep; 2024 Apr; 14(1):9764. PubMed ID: 38684762
[TBL] [Abstract][Full Text] [Related]
9. Lipid Metabolism-Related Gene Markers Used for Prediction Prognosis, Immune Microenvironment, and Tumor Stage of Pancreatic Cancer.
Shu Y; Huang H; Gao M; Xu W; Cao X; Jia X; Deng B
Biochem Genet; 2024 Apr; 62(2):931-949. PubMed ID: 37505298
[TBL] [Abstract][Full Text] [Related]
10. STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance.
Li T; Zhang W; Niu M; Wu Y; Deng X; Zhou J
Front Immunol; 2024; 15():1342647. PubMed ID: 38550593
[TBL] [Abstract][Full Text] [Related]
11. Analysis of single nuclear chromatin accessibility reveals unique myeloid populations in human pancreatic ductal adenocarcinoma.
Pratt HG; Ma L; Dziadowicz SA; Ott S; Whalley T; Szomolay B; Eubank TD; Hu G; Boone BA
Clin Transl Med; 2024 Mar; 14(3):e1595. PubMed ID: 38426634
[TBL] [Abstract][Full Text] [Related]
12. Modeling of new markers for the diagnosis and prognosis of pancreatic cancer based on the transition from inflammation to cancer.
Zhou Y; Huang B; Zhang Q; Yu Y; Xiao J
Transl Cancer Res; 2024 Mar; 13(3):1425-1442. PubMed ID: 38617519
[TBL] [Abstract][Full Text] [Related]
13. Identification of copy number variation-driven molecular subtypes informative for prognosis and treatment in pancreatic adenocarcinoma of a Chinese cohort.
Zhan Q; Wen C; Zhao Y; Fang L; Jin Y; Zhang Z; Zou S; Li F; Yang Y; Wu L; Jin J; Lu X; Xie J; Cheng D; Xu Z; Zhang J; Wang J; Deng X; Chen H; Peng C; Li H; Zhang H; Fang H; Wang C; Shen B
EBioMedicine; 2021 Dec; 74():103716. PubMed ID: 34839264
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of disulfidptosis-related lncRNAs for predicting prognosis and response of immunotherapy in pancreatic adenocarcinoma.
Guo J; Wang Y; Hou J; Zhao T; Wei Z
Transl Cancer Res; 2024 Mar; 13(3):1336-1350. PubMed ID: 38617527
[TBL] [Abstract][Full Text] [Related]
15. IL-7R Expression Correlates with Prognosis in Breast Cancer.
Yu X; Zhang H; Liu J; Hou C; Zhang H; Yang Z
Comb Chem High Throughput Screen; 2024 Apr; ():. PubMed ID: 38638044
[TBL] [Abstract][Full Text] [Related]
16. Identification of the molecular subtype and prognostic characteristics of pancreatic cancer based on CD8 + T cell-related genes.
Xu D; Wang Y; Chen Y; Zheng J
Cancer Immunol Immunother; 2023 Mar; 72(3):647-664. PubMed ID: 36036290
[TBL] [Abstract][Full Text] [Related]
17. Recurrence prediction of lung adenocarcinoma using an immune gene expression and clinical data trained and validated support vector machine classifier.
Shen Y; Goparaju C; Yang Y; Babu BA; Gai W; Pass H; Jiang G
Transl Lung Cancer Res; 2023 Oct; 12(10):2055-2067. PubMed ID: 38025809
[TBL] [Abstract][Full Text] [Related]
18. Identification of Novel Tumor Pyroptosis-Related Antigens and Pyroptosis Subtypes for Developing mRNA Vaccines in Pancreatic Adenocarcinoma.
Lin Q; Liang L; Wang Q; Wang X; You Y; Rong Y; Zhou Y; Guo X
Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672082
[TBL] [Abstract][Full Text] [Related]
19. Machine Learning Developed a MYC Expression Feature-Based Signature for Predicting Prognosis and Chemoresistance in Pancreatic Adenocarcinoma.
Dong B; Zhang Y; Gao H; Liu J; Li J
Biochem Genet; 2024 Jan; ():. PubMed ID: 38245886
[TBL] [Abstract][Full Text] [Related]
20. Berberine chloride suppresses pancreatic adenocarcinoma proliferation and growth by targeting inflammation-related genes: an in silico analysis with in vitro and vivo validation.
Ruan LJ; Jiao JY; Cheng C; Zhang Y; Cao ZQ; He B; Chen Z
Cancer Chemother Pharmacol; 2024 Mar; ():. PubMed ID: 38502348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
